Funding Resulting from REACH Collaborations

Grants involving more than one REACH Campus - made possible through the use of REACH Resources/Infrastructure:

"“A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is used in Combination with Statin Therapy in Patients with Clinically Evident Cardiovascular Disease”

Focus Groups: Clinical and Translational Research
PI: Luis Gruberg (Stony Brook University Medical Center)
SUNY Campuses: Downstate, Buffalo, Upstate
Sponsor: Fourier (AMGEN)
Trial Start Date: Anticipated most, if not all, participating sites will begin enrollment April 2014
Trial End Date: 2020
Per Patient Amount: Varies by site (approximately $20,000/per pt – for pts who complete 5-year participation)
Recruitment: Up to 40 pts/site
 

"Isoprenoid Metabolism in the Retina"

Focus Groups: SUNY Eye Institutes
PI: Steven Fliesler (University at Buffalo)
SUNY Campuses: Buffalo, Upstate
Sponsor: NIH NEI 2R01EY007361-19
Award Period: 12/01/2012 to 12/31/2015
Award Amount: $1,955,213 Total Costs $1,644,830 Direct Costs 310,383 Indirect Costs
 

"Nanoscale engineering of a biocompatible corneal prosthesis"

Focus Groups:SUNY Eye Institute
PI: William J. Brunken (Downstate Medical Center)
SUNY Campuses: /td> Downstate, SUNY College of Nanoscale Science & Engineering
Sponsor: New York State Department of Health – ECRIP
Award Period: 07/1/2012  to 6/30/2013
Award Amount: $110,000;   includes $35,000 for faculty development & retention
 

"Molecular and Clinical Pharmacology of Retinopathy of Prematurity"

Focus Groups: SUNY Eye Institute
 Clinical and Translational Research
PI: Jacob V. Aranda (Downstate Medical Center)
SUNY Campuses: Downstate, Buffalo, Stony Brook
Sponsor: NIH EKSNICHHD 1U54HD071594-01
Award Period: 09/30/2011 to 06/30/2016
Award Amount: $3,689,741 Total Costs$2,565,823 Direct Costs $1,123,918 Indirect Costs
 

"State University of New York (SUNY) NEXT (Network of Excellence in Neuroscience Clinical Trials) Clinical Site"

Focus Group: Clinical and Translational Research
PI: Steven R. Levine (Downstate Medical Center)
SUNY Campuses: Downstate, Buffalo, Stony Brook, Upstate
Sponsor: NIH NINDS 1U10NS077378-01
Award Period: 09/30/2011 to 08/31/2018 (7 yrs Total)
Award Amount:$646,625 (yrs 1-2) Total Costs$542,500 Direct Costs $104,125 Indirect Costs
 

Individual Trials as part of SUNY NEXT*:

“NN101 SMA (Spinal Muscular Atrophy Biomarkers in the Immediate Postnatal Period of Development)”

SUNY Campuses:  Upstate
Per Patient Amount: $6,471
Recruitment:  Competitive enrollment – looking to enroll total of 54 pts
Start Date: 12/2012
End Date 11/2014
 

“NN102 SPRINT-MS Study (Ibudilast)”

SUNY Campuses: Buffalo, Upstate, Stony Brook
Per Patient Amount: $15,188
Recruitment: as of April 2014 enrollment will become competitive (total 250 pts)
Start Date: 3/2014
End Date: 6/2016
*SUNY NEXT sites continue to complete feasibility questionnaires for potential studies and 
SUNY sites indicate an interest in participating in many of these if funded.  Site selection varies from study to study but SUNY NEXT sites will be participating in additional studies going forward (each site is guaranteed participation in at least two studies).
 

“Optimization of Optical Coherence Tomography as a Biomarker for Parkinson’s Disease”

Focus Group: SUNY Eye Institute
PI: Ivan Bodis-Wollner (Downstate Medical Center)
SUNY Campuses: Downstate, SUNY College of Optometry
Sponsor: Michael J. Fox Foundation
Award Period: 04/1/2010 to 03/31/2012
Award Amount: $362,882 Total Costs $329,893 Direct Costs $32,989 Indirect Costs
 

“SUNY Downstate Vascular Stem Cell Genome Consortium"

Focus Group: SUNY Eye Institute
PI: Olcay Batum; Co-PI:  William J. Brunken (Downstate Medical Center)
SUNY Campuses: Downstate and Upstate Medical University
Sponsor: NY DHS – NYStem Program
Award Period:  11/01/2008 – 4/30/2010
Award Amount: $120,000 Total Costs $120,000 Direct Costs $0 Indirect Costs